Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19

Clinical Characteristics, Treatments and Outcomes of 18 Lung Transplant Recipients with COVID-19

We report clinical features, treatments and outcomes in 18 lung transplant recipients with laboratory confirmed SARS-CoV-2 infection. We performed a single center, retrospective case series study of lung transplant recipients, who tested positive for SARS-CoV-2 between 1 February 2020 and 1 March 20...

Full description

Bibliographic Details
Main Authors:	René Hage, Carolin Steinack, Fiorenza Gautschi, Susan Pfister, Ilhan Inci, Macé M. Schuurmans
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Transplantology
Subjects:	SARS-CoV-2 viral infection hyperinflammation cytokine storm syndrome dexamethasone remdesivir
Online Access:	https://www.mdpi.com/2673-3943/2/2/22

Similar Items

Calcineurin inhibitors revisited: A new paradigm for COVID-19?
by: René Hage, et al.
Published: (2020-07-01)

COVID‐19: lambda interferon against viral load and hyperinflammation
by: Evangelos Andreakos, et al.
Published: (2020-05-01)

The NLRP3 inflammasome is essential for IL-18 production in a murine model of macrophage activation syndrome
by: Tara A. Gleeson, et al.
Published: (2024-07-01)

Light as a Cure in COVID-19: A Challenge for Medicine
by: Laura Marinela Ailioaie, et al.
Published: (2022-09-01)

Immunomodulators and SARS-CoV-2: Management of the Dysregulated Immune Response
by: Chandramouli Mandya Thimmaiah, et al.
Published: (2023-04-01)

Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes
by: Amy Armstrong, et al.
Published: (2024-09-01)

Corrigendum: Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes
by: Amy Armstrong, et al.
Published: (2024-10-01)

Dexamethasone in critically ill patients admitted to intensive care unit with COVID-19 pneumonia
by: Omer Emgin, et al.
Published: (2023-06-01)

Corrigendum: The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
by: Aliakbar Hasankhani, et al.
Published: (2024-05-01)

The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
by: Aliakbar Hasankhani, et al.
Published: (2023-02-01)

A systematic review and meta‐analysis of investigating the mutual impact of COVID‐19 and psoriasis: Focusing on COVID‐19 course in psoriasis and the opinion on biologics in this setting
by: Nazila Ghoreishi Amin, et al.
Published: (2023-11-01)

Current Understanding of the Innate Control of Toll-like Receptors in Response to SARS-CoV-2 Infection
by: Hi Eun Jung, et al.
Published: (2021-10-01)

COVID-19 Is a Multifaceted Challenging Pandemic Which Needs Urgent Public Health Interventions
by: Carlo Contini, et al.
Published: (2020-08-01)

Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients
by: Tamara Seitz, et al.
Published: (2022-07-01)

Influence of mycophenolate mofetil dosage and plasma levels on the occurrence of chronic lung allograft dysfunction in lung transplants: a retrospective cohort analysis
by: Carolin Steinack, et al.
Published: (2022-07-01)

Dexamethasone as a Treatment of COVID-19
by: Abdullah Alkattan, et al.
Published: (2020-12-01)

COVID-Related Chronic Allograft Dysfunction in Lung Transplant Recipients: Long-Term Follow-up Results from Infections Occurring in the Pre-vaccination Era
by: René Hage, et al.
Published: (2022-09-01)

Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 Infections
by: Asaba CN, et al.
Published: (2024-07-01)

Immunouniverse of SARS-CoV-2
by: Dennis Jiménez, et al.
Published: (2022-10-01)

Transient Leukopenia Induced by Combination Therapy for Severe SARS-CoV-2 Pneumonia
by: Sierra Sullivan, et al.
Published: (2022-10-01)

Transbronchial Cryobiopsy Compared to Forceps Biopsy for Diagnosis of Acute Cellular Rejection in Lung Transplants: Analysis of 63 Consecutive Procedures
by: Carolin Steinack, et al.
Published: (2022-06-01)

Anti-CD6 humanized monoclonal antibody itolizumab, halts disease progression and severity of acute respiratory distress syndrome in COVID-19 disease: A case study
by: Hemant P Thacker, et al.
Published: (2021-01-01)

From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry
by: Darja Kanduc
Published: (2021-09-01)

Predictors of Duration of Hospital Stay in COVID-19 Disease: A Retrospective Study
by: KP Vijayalakshmi, et al.
Published: (2022-10-01)

Serum soluble Fas ligand is a severity and mortality prognostic marker for COVID-19 patients
by: Kiarash Saleki, et al.
Published: (2022-08-01)

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
by: Yi-Hsuan Lai, et al.
Published: (2023-12-01)

Remdesivir in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis
by: Zia Navidi, et al.
Published: (2024-09-01)

Curtailing virus-induced inflammation in respiratory infections: emerging strategies for therapeutic interventions
by: Alexander A. Globenko, et al.
Published: (2023-05-01)

Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study
by: Spagnuolo V, et al.
Published: (2022-10-01)

Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
by: Job J. Engel, et al.
Published: (2023-08-01)

Changes in the Cytokine Profile in Patients During COVID-19 Infection
by: Ivanov N., et al.
Published: (2023-12-01)

Immunometabolic Profile of Nigerian COVID-19 Patients
by: Ganiyu Olatunbosun Arinola, et al.
Published: (2023-07-01)

Practical approach to early postoperative management of lung transplant recipients
by: Macé M. Schuurmans, et al.
Published: (2013-04-01)

COVID-19 in kidney transplant recipients; an Indian experience
by: Bendalam Gouthami, et al.
Published: (2022-04-01)

Clinical characteristics and courses of 200 patients hospitalized for COVID-19 during the second and third waves at Fujita Health University Okazaki Medical Center in Japan
by: Masamichi Hayashi, et al.
Published: (2023-02-01)

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient
by: Tanino Y, et al.
Published: (2024-02-01)

COVID-19-Associated Lung Fibrosis: Two Pathways and Two Phenotypes, Lung Transplantation, and Antifibrotics
by: René Hage, et al.
Published: (2022-07-01)

Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient [Corrigendum]
by: Tanino Y, et al.
Published: (2024-03-01)

COVID-19 in Lung Transplant Recipients: A Report on 10 Recent Cases
by: Lea Reemann, et al.
Published: (2024-04-01)

Insights into biological therapeutic strategies for COVID-19
by: Xiaolong Tian, et al.
Published: (2021-03-01)